Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis

A technology of thiobenzamide and thioacetamide, applied in the direction of organic chemistry, etc., can solve the problems of large discharge pollution of three wastes, complicated operation and the like

Inactive Publication Date: 2014-11-26
CHONGQING SHENGHUAXI PHARMA CO LTD +1
View PDF10 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0013] The operation steps of the method are to place 4-hydroxybenzonitrile, hydrogen sulfide gas and solvent water in a closed high-pressure device, and heat to 70° C. for an addition reaction to obtain 4-hydroxythio

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis
  • Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis
  • Preparation method of 3,4-substitituted thiobenzamide and application of 3,4-substitituted thiobenzamide in febuxostat synthesis

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0023] Table 1 The research results of changing the reaction solvent and temperature and other factors

[0024]

[0025] The 4-hydroxythiobenzamide obtained by the above method is used as a raw material to synthesize Febuxostat according to the methods of patents JP6-329647 / 1994 and JP10-45733 / 1998.

[0026] Example 2

Embodiment 2

[0028] Table 2 The research results of changing the reaction solvent and temperature and other factors

[0029]

[0030] Using the 4-hydroxy-3-nitrothiobenzamide obtained by the above method as a raw material, Febuxostat was synthesized by referring to the method of patent EP0513379 / 1992.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention relates to a preparation method of 3,4-substituted thiobenzamide. The 3,4-substituted thiobenzamide prepared by the method can be used to synthesis of febuxostat, a novel drug for treating gout.

Description

technical field [0001] The invention discloses a method for preparing 3,4-substituted thiobenzamide, and the product of the method can be used in the synthesis of new anti-gout drug Febuxostat. Background technique [0002] Febuxostat was first approved by the European Medicines Agency (EMA) in April 2008 for the treatment of hyperuricemia and related diseases caused by it, such as gout. The chemical name of febuxostat is: 2-(3-cyano-4-isobutoxy)phenyl-4-methyl-5-thiazolecarboxylic acid, and its chemical structure is as follows. [0003] [0004] The core part of the molecular structure of febuxostat is a 2-substituted phenylthiazole derivative, and its synthesis is mainly based on 3,4-substituted thiobenzamide (2) and 2-halogenated ethyl acetoacetate The ester (3) is formed by cyclization, and the reaction formula is as follows. [0005] [0006] According to the description of the patent EP0513379 / 1992, compound 2 and 2-halogenated ethyl acetoacetate (3) are synthe...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
IPC IPC(8): C07C327/48C07D277/56
Inventor 李能刚
Owner CHONGQING SHENGHUAXI PHARMA CO LTD
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products